https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Int J Hyperthermia 2006 Nov;22(7):613-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Int J Hyperthermia 2006 Nov;22(7):613-212006-11-01 00:00:002006-11-01 00:00:00Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-952006-11-01 00:00:002006-11-01 00:00:00Hyperthermia and immunity. A brief overview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Gan To Kagaku Ryoho 2006 Nov;33(12):1739-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Gan To Kagaku Ryoho 2006 Nov;33(12):1739-412006-11-01 00:00:002019-02-15 08:44:38[Successful immunotherapy combined with hyperthermia therapy for cancer patients]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-1000
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-10002006-11-01 00:00:002021-11-15 15:39:05Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Cancer Res. 2006 Nov;66(21):10247-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Cancer Res. 2006 Nov;66(21):10247-522006-11-01 00:00:002019-02-15 08:59:57Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-26 / Mol. Cancer 2006 Oct;5:49
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-26 / Mol. Cancer 2006 Oct;5:492006-10-26 00:00:002019-02-15 08:35:27Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-23 / Clin. Immunol. 2007 Jan;122(1):18-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-23 / Clin. Immunol. 2007 Jan;122(1):18-272006-10-23 00:00:002019-02-15 08:52:20In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-12 / Blood 2007 Feb;109(3):1165-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-12 / Blood 2007 Feb;109(3):1165-732006-10-12 00:00:002019-02-15 08:44:37Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-452006-10-10 00:00:002019-02-15 09:24:12Vaccination therapy in prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-122006-10-01 00:00:002019-02-15 08:32:38Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
